Roche reported that the US Food and Drug Administration (FDA) has provided 510(k) clearance and a Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver for its cobas liat panels for multiplex testing of sexually transmitted infections...
Poxel SA, a biopharmaceutical firm at the clinical stage focusing on developing groundbreaking therapies for chronic serious diseases characterized by metabolic pathophysiology, such as metabolic dysfunction-associated steatohepatitis (MASH)...
Hoth Therapeutics, Inc., a biopharmaceutical firm centered on patients, is pleased to announce progress in its intellectual property holdings by acquiring and expanding patent applications related to its cutting-edge therapeutic pipeline...
Opella, the Consumer Healthcare division of Sanofi, announced that the US Food and Drug Administration (FDA) has removed a clinical hold on its proposed actual use trial (AUT) aimed at facilitating the transition of Cialis (tadalafil) from...
BioNxt Solutions Inc, a bioscience firm focused on cutting-edge drug delivery systems, is thrilled to share a significant achievement in its research and development progress. The firm is moving its innovative R&D tasks to the Gen-Plus Contract...
The Competition Commission approved the merger of nine entities with the pharmaceutical company Sequent Scientific Ltd (SSL). "The suggested merger entails a sequence of linked actions executed for the integration of SRL, Viyash, Symed, Appcure...
Glenmark Pharmaceuticals announced that its US division has introduced the anticoagulant Phytonadione injectable emulsion. Glenmark Pharmaceuticals Inc., USA has introduced a 10 mg/mL injectable emulsion of Phytonadione in single-dose ampules...
InnoCare Pharma and KeyMed Biosciences announced that they, along with their joint venture, have collectively signed an exclusive licensing agreement with Prolium Bioscience (Prolium) for the advancement and marketing of ICP-B02 (CM355)...
GSK plc announced that the European Commission has authorized Jemperli (dostarlimab) in conjunction with chemotherapy (carboplatin and paclitaxel) as a first-line therapy for adult patients with primary advanced or recurrent endometrial cancer...
SCHOTT Pharma, a leader in drug containment and delivery solutions, introduces the next generation of SCHOTT TOPPAC infuse polymer syringes, a system aimed at enhancing safety, efficiency, and sustainability in the healthcare sector. Created in...
, CDSCO.jpg)
